Home » Newsletters » BioWorld

BioWorld

July 2, 1991

View Archived Issues

TWO CYTOKINES ARE BETTER THAN ONE

XOMA LICENSES MAb TO STERLING

HEPARIN-REMOVAL DEVICE TRIALS

EPITOPE HALTS DISTRIBUTION OF AIDS TEST

LIPOSOME CO. DEVICE DETECTS BLOOD MARKER

GI TAKES EPO APPEAL TO SUPREME COURT

EPO ARBITRATOR TELLS AMGEN TO PAY $164M

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...